Many people are looking for easy and successful ways to lose excess fat, and currently the Monjaro and Ozambik slimming syringes or injections are gaining most attention these days as an easy and successful way to lose weight without any surgical intervention, but some consider them a magic solution, and misuse them, ignoring their side effects and potential risks. So, what are these? injections? Who can use them? Here we will answer all your frequently asked questions.


What are Mongaro and Ozambik injections?


Monjaro and Ozambik were originally injections intended to treat diabetes, but they are famous for their use in weight loss. It was discovered that one of their side effects is weight loss, so they were used for this purpose for those who suffer from obesity when traditional methods, such as diet and exercise, fail. (1)


These injections require a medical prescription and may not be used by anyone without consulting a physician about their safety, how to use them, and the appropriate dose, as a person must meet certain conditions in order for the physician to allow this person to use these injections to lose excess weight. (1)


How do they help lose weight?


Monjaro contains the active ingredient "Terzepatide", while Ozembek contains "Semaglutide", both of which mimic the action of a natural hormone in the body called "GLP-1", which helps suppress appetite, make you feel full, and slow stomach emptying. These injections contain higher amounts of the natural GLP-1 hormone, which makes the person feel full, his stomach is full most of the time, and eats much less than before, and this helps in losing weight. (2)


How much weight loss is expected? Which is better: Monjaro or Ozembek?


Slimming injections are the most effective in terms of expected weight loss among all types of weight loss medications, and among the injections, Mongaro is currently the most powerful slimming injection, and also the most expensive, according to several studies:


  • Studies on Semaglutide (the active ingredient in Ozembik) have shown that a weekly dose of 2.4 mg of the drug helps to lose approximately 15% of body weight after 68 weeks of use, which is equivalent to approximately 15 kilograms for a person weighing 100 kilograms.


  • In contrast, in another study of Mongaro injections, more than half of the study participants lost 21% of their body weight when using the highest dose (15 mg/week) of tirzepatide (the active ingredient in Mongaro) after 72 weeks of use. This amount of weight loss is unmatched by any medication or method other than Sleeve gastrectomy and bariatric surgery.


  • In the most recent 2023 study, Monjaro and Ozambik were compared together for weight loss. After 3 months, average weight loss was about 6% for Mongaro users, compared to about 4% for Ozambik users. After 6 months, the average weight loss on Monjaro was 10%, compared to 6% on Ozambik. After 12 months, the rate was 15% for Monjaro, compared to about 8% for Uzbek.


How to take Mongaro and Ozambik injections?


The injections are given in gradually increasing doses in the form of subcutaneous injections once a week, either in the abdomen, thigh, or upper arm, almost similar to an insulin pen. (1)


It is necessary to follow a diet and exercise alongside these injections. To get a successful result. (1)


Are they suitable for me? What are the terms of use?


Mongaro and Ozambik injections are not for everyone. These injections are allowed for those who suffer from type 2 diabetes or obesity, and not for those who just want to get rid of a few kilograms of excess weight. Therefore, you should consult your doctor before you start using it, as he will decide whether you need it or not, and whether it is safe and suitable for you.


In general, they can be used for weight loss if: (3)


  • A body mass index (BMI) of 30 or higher, or
  • A BMI of 27 or higher for people who have at least one of the coditions associated with obesity, such as hypertension, diabetes, or dyslipidemia, among others.


Contraindications

Monjaro or Ozembek are contraindicated if you have a family or personal history of certain types of thyroid cancer.


Warnings

It is recommended to avoid or consult a doctor before using both Ozempic and Monjaro if: (4) (5)

  • History of pancreatitis.
  • History of gallbladder diseases.
  • Chronic kidney disease.
  • Diabetic retinopathy.
  • Pregnancy and breastfeeding.


It is also recommended to consult a doctor before using Monjaro in the event of severe stomach or intestinal disease.


Is it safe?


Mongaro and Ozambik slimming injections are generally safe if used after consulting a doctor, and according to his instructions. Most of the side effects they cause are disturbing intestinal symptoms, which usually improve or disappear in the first days or a few weeks, such as: (4)(5)


  • Nausea, which is the most common symptom.
  • Vomiting.
  • Diarrhea.
  • Heartburn.
  • Abdominal pain.
  • Constipation.


However, the manufacturers of these injections warn that they may increase the risk of developing some serious health problems, the most important of which are: (4)(5)


  • pancreatitis.
  • Gallstones and cholecystitis.
  • Severe stomach problems.
  • Hypoglycemia.


What are the alternatives?


If you are overweight or obese, the first option is to follow a healthy diet and exercise regularly, but this solution may not suit everyone. (6)


Before you decide to use medications or injections for slimming, or resort to Sleeve gastrectomy or other bariatric surgeries, it is necessary to consult a specialist doctor to help you understand what suits your condition and weight, and to explain to you the potential pros and cons.


Remember that obesity is not just an aesthetic problem, but rather a serious and chronic disease that causes serious health complications if it is not treated, including diabetes, cardiovascular disease, kidney disease, and some types of cancer. Therefore, do not postpone starting your treatment plan to get rid of obesity now. (6)



References:

1.Drugs.com: Mounjaro vs Ozempic: How do they compare?

2.New England Journal of Medicine (NEJM): Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes

3.U.S. Food and Drug Administration: FDA Approves New Medication for Chronic Weight Management

4.Mounjaro: Official Website

5.Ozempic: Official Website

6.National Institute of Diabetes and Digestive and Kidney Diseases: Treatment for Adult Overweight and Obesity